Innovative Testing Genomic Expression’s OneRNA™ test offers a targeted approach to cancer treatment by linking RNA sequencing to approved therapies and clinical trials, presenting a strong value proposition for healthcare providers seeking personalized medicine solutions.

Growth Potential With recent funding of $4.4 million and revenue estimates between one and ten million dollars, the company is positioned for expansion, creating opportunities to scale their RNA-based diagnostics and attract partnerships with larger biotech firms.

Market Differentiation Offering a unique approach that addresses the gap in survival benefits for cancer drugs, Genomic Expression can position itself as a leader in precision oncology, appealing to hospitals and research institutions looking for innovative diagnostic tools.

Technology Leverage Utilizing modern tech stacks such as React, Webpack, and cloud-based solutions, the company is well-equipped to enhance its digital presence and streamline customer engagement, helping to accelerate sales and partnerships.

Partnership Opportunities By aligning with industry leaders in genomics and biotech companies with complementary products, Genomic Expression can expand its client base and leverage shared research efforts to drive new sales channels.